Innocan Pharma To List On NYSE American With Concurrent Offering
(RTTNews) - Innocan Pharma (INNPF) announced that it anticipates to list on NYSE American on or around January 7, 2026. Innocan is also conducting a concurrent offering of its securities.
Innocan expects that its common shares will continue to trade on the OTC Markets' OTCQB until the close of the market on or about January 6, 2026. Upon effectiveness of the listing on the NYSE American, trading on the OTCQB will terminate. Innocan's shares will continue to trade on the Canadian Securities Exchange under the symbol, INNO.
For More Such Health News, visit rttnews.com.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.